Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkin Lymphoma

Explore clinical trials studying Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

214 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Non-Hodgkin Lymphoma trial results

Recruiting

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

NCT06059391

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +34 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • DFCI/BWH Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma

NCT05950165

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Tri-Service General Hospital - Neihu Branch - Hematology Taipei, Taiwan
  • Taipei Medical University - Shuang Ho Hospital - Oncology New Taipei City, Taipei Special Municipality, Taiwan
  • National Taiwan University Hospital Yunlin Branch Huwei, Taiwan
  • Chi-Mei Medical Center Tainan, Taiwan
View Trial Details
Recruiting

Epco, Zanu, Ritux for R/R FL or MZL

NCT06563596

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details
Recruiting

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

NCT03666000

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +27 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute Emory University Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Recruiting

Study of AXT-1003 in Subjects With Advanced Malignant Tumors.

NCT06484985

Conditions
Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Hunan Cancer Hosptial Changsha, China
  • Fujian Cancer Hospital Fuzhou, China
  • Sun Yat-Sen University Cancer Center Guangzhou, China
View Trial Details
Recruiting

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

NCT06357754

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +20 more
Locations
  • Local Institution - 0016 Portland, Oregon, United States
  • Ut Southwestern Dallas, Texas, United States
  • Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States
  • Local Institution - 0004 Madison, Wisconsin, United States
View Trial Details

Related conditions